Chiral switch: Between therapeutical benefit and marketing strategy
G Hancu, A Modroiu - Pharmaceuticals, 2022 - mdpi.com
Chirality of pharmaceutical substances is an important aspect in drug research because it
determines how enantiomers will interact with chiral biological targets. Enantiomers of a …
determines how enantiomers will interact with chiral biological targets. Enantiomers of a …
Mechanical factors in arterial aging: a clinical perspective
MF O'rourke, J Hashimoto - Journal of the American College of Cardiology, 2007 - jacc.org
The human arterial system in youth is beautifully designed for its role of receiving spurts of
blood from the left ventricle and distributing this as steady flow through peripheral …
blood from the left ventricle and distributing this as steady flow through peripheral …
Expert consensus document on arterial stiffness: methodological issues and clinical applications
S Laurent, J Cockcroft, L Van Bortel… - European heart …, 2006 - academic.oup.com
In recent years, great emphasis has been placed on the role of arterial stiffness in the
development of cardiovascular diseases. Indeed, the assessment of arterial stiffness is …
development of cardiovascular diseases. Indeed, the assessment of arterial stiffness is …
Pulse pressure—a review of mechanisms and clinical relevance
AM Dart, BA Kingwell - Journal of the American College of Cardiology, 2001 - jacc.org
The goal of this study was to review the origin, clinical relevance and treatment of pulse
pressure (PP). Elevated PP is increasingly being recognized as a risk factor for …
pressure (PP). Elevated PP is increasingly being recognized as a risk factor for …
Clinical applications of arterial stiffness, Task Force III: recommendations for user procedures
LM Van Bortel, D Duprez… - American journal of …, 2002 - academic.oup.com
In vivo arterial stiffness is a dynamic property based on vascular function and structure. It is
influenced by confounding factors like blood pressure (BP), age, gender, body mass index …
influenced by confounding factors like blood pressure (BP), age, gender, body mass index …
Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left …
GF Mitchell, LA Moyé, E Braunwald, JL Rouleau… - Circulation, 1997 - Am Heart Assoc
Background There is increasing evidence of a link between conduit vessel stiffness and
cardiovascular events, although the association has never been tested in a large post …
cardiovascular events, although the association has never been tested in a large post …
Non–insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes: the ARIC study
Background Cardiovascular diseases are the most common cause of disability and death
among subjects with non–insulin-dependent diabetes mellitus (NIDDM). The atherosclerotic …
among subjects with non–insulin-dependent diabetes mellitus (NIDDM). The atherosclerotic …
Validation of carotid artery tonometry as a means of estimating augmentation index of ascending aortic pressure
Our objective was to validate a carotid artery tonometry–derived augmentation index as a
means to estimate augmentation index (AI) of ascending aortic pressure under various …
means to estimate augmentation index (AI) of ascending aortic pressure under various …
Cardiac and arterial interactions in end-stage renal disease
GM London, AP Guerin, SJ Marchais, B Pannier… - Kidney international, 1996 - Elsevier
Cardiac and arterial interactions in end-stage renal disease. Although cardiac hypertrophy is
a frequent complication of end-stage renal disease (ESRD), relatively little is known about …
a frequent complication of end-stage renal disease (ESRD), relatively little is known about …
Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study
P Boutouyrie, A Achouba, P Trunet, S Laurent - Hypertension, 2010 - Am Heart Assoc
The β-blocker atenolol is less effective than angiotensin-receptor blockers and calcium-
channel blockers for reducing central blood pressure (BP). The trial was designed to …
channel blockers for reducing central blood pressure (BP). The trial was designed to …